• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Agilent Technologies

Agilent Technologies

Agilent Technologies Inc A

Last Price$46.58Day Change (%)-0.19%
Open Price$46.72Day Change ($)-0.09
Day Range46.42–46.7952-Week Range33.12–47.18

As of Fri 7/22/2016 5:13:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Cancer Diagnostics Device Market to Grow 18.07% by 2020 - Key Vendors are Agilent Technologies , Qiagen & Roche Diagnostics - Research and Markets

    Global Cancer Diagnostics Device Market to Grow 18.07% by 2020 - Key Vendors are Agilent Technologies , Qiagen & Roche Diagnostics - Research and Markets

  2. Global Genetic Testing Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Abbott Labs, Roche Diagnostics, Myriad Genetics - Research and Markets

    Global Genetic Testing Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Abbott Labs, Roche Diagnostics, Myriad Genetics - Research and Markets

  3. Nucleic Acid Purification Market 2016: New Life Science Dashboard™ from Percepta observes decreased number of end-users but projects unit growth in the dynamic $1 Billion market in North America and ...

    Nucleic Acid Purification Market 2016: New Life Science Dashboard™ from Percepta observes decreased number of end-users but projects unit growth in the dynamic $1 Billion market in North America and Europe

  4. Molecular Cytogenetics Market 2015-2022: Fluorescence In Situ Hybridization, Array-based Technology - Global Strategic Business Report 2016 - Research and Markets

    Molecular Cytogenetics Market 2015-2022: Fluorescence In Situ Hybridization, Array-based Technology - Global Strategic Business Report 2016 - Research and Markets

  5. What's the Best Way to Play a Large-Growth Rally?

    You'll be surprised at which funds are poised for a large-growth rebound.

  6. Middle East/Africa: Regional Economic Review – 3Q 2013

    Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...

  7. What the NHL Playoffs Can Teach Investors

    Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...

  8. Selected American Shares Annual Review 2014

    This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...

  9. Semiconductor Industry Outlook – April 2011

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.